A molecular switch has the ability to turn on a substance in animals that repairs neurological damage in disorders such as multiple sclerosis (MS), researchers have discovered. The early research in animal models could advance an already approved Food …
New twist to fight against autoimmune diseases
Scientists an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases. New research has implications for multiple sclerosis, type 1 diabetes and inflammatory bowel disease. It also will …
MS linked to variant of common herpes virus
Researchers have developed a new method to separate between two different types of a common herpes virus (HHV-6) that has been linked to multiple sclerosis. By analyzing antibodies in the blood against the most divergent proteins of herpesvirus 6A and …
Industry executives: Profits drive rising prices for MS drugs
Pharmaceutical industry executives, speaking confidentially, paint a frank picture of the rationale behind the price of medication available to people with multiple sclerosis.
Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown. Presently, they have no hope for a cure. Researchers have now identified a molecule named ALCAM which, once blocked, delays the progression of the di…
Scientists find molecular key to body making healthy T cells
In a finding that could help lead to new therapies for immune diseases like multiple sclerosis and IBD, scientists report identifying a gene and family of proteins critical to the formation of mature and fully functioning T cells in the immune system.
New treatment may reverse celiac disease
A phase 2 clinical trial using a new technology show it is possible to induce immune tolerance to gluten in individuals with celiac disease. After treatment with the technology, the patients were able to eat gluten with a substantial reduction in infla…
Surprise contributor to multiple sclerosis
The discovery suggests new avenues for devising treatments and is a vital step toward finding a cure.
Genomic map implicates broad immune cell involvement in multiple sclerosis
In a study of 115,803 individuals, the authors have identified 233 sites or loci in the human genome that contribute to the onset of MS. This is the largest study to date in MS.
Researchers relate neuropsychological tests with real-life activity in multiple sclerosis
To best serve the clinical needs of individuals with MS, neuropsychological testing needs to be viewed in larger context comprising non-cognitive variables, such as motor ability and demographic values, fatigue and depression, and disease activity and …